Advertisement
Home Tags Cancer: Lung

Tag: Cancer: Lung

For patients treated for T1a renal cell carcinoma

X-Rays Have Low Diagnostic Yield for Pulmonary Metastases

0
Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance
In patients with lung cancer as the cause of death

Nonsolid Nodules Unlikely to Cause Death in Lung Cancer

0
Lung cancers that manifest as nonsolid nodules seem to have indolent course
Many patients with advanced stage non-small-cell lung cancer might live longer if treated surgically

Surgery Tied to Longer Survival for Lung Cancer Patients

0
Too few may be getting procedure, research suggests
Many family physicians discuss low-dose computed tomography screening for lung cancer with patients at high risk

Many PCPs Discuss Low-Dose CT Screening With Patients

0
But more than half report making one or no screening recommendations in past year
A new smartphone app may help lung cancer patients live longer and better by monitoring their symptoms and alerting doctors to potential problems

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

0
Researchers found tracking symptoms, alerting doctors to problems early led to longer survival
Older lung cancer patients are surviving longer when they have lung cancer surgery

Lung Cancer Resection Linked to Longer Survival for Older Patients

0
Researchers find those 65 and older survive longer when they have surgery
Participants with a negative low-dose computed tomography prevalence screen (T0) have lower incidence of lung cancer and lung cancer-specific mortality than all participants with a T0 screen

Low Lung Cancer Incidence With Negative CT Prevalence Screen

0
Incidence of lung CA, lung CA-related mortality lower than for all participants with prevalence screen
The CYP3A7*1C allele appears to be associated with mortality and disease progression in specific cancers

CYP3A7*1C Allele Linked to Cancer Mortality, Progression

0
Associated with adverse outcomes in breast cancer, lung cancer, chronic lymphocytic leukemia
Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

0
Drug approval expanded to include patients with ROS1-positive NSCLC
Dietary glycemic index is associated with lung cancer risk

Dietary Glycemic Index Linked to Lung Cancer Risk

0
More pronounced link for never smokers, squamous cell carcinoma, those with <12 years education